The Biotech Growth Trust PLC (“the Company”)
Compliance with Market Abuse Regulation
11 October 2019
The Company confirms that:
a) all inside information which the Directors and Company may
have had has been notified to a Regulated Information Service (“RIS”);
b) the Company’s net asset value per share is calculated and
announced through a RIS on a daily basis; and
c) the Company has no reason to believe that there will be any
material difference between the net asset value per share as at close of
business on Monday, 30 September 2019, which was announced on Tuesday,1
October 2019, and the financial information to be published in the
announcement of its results for the half year ended 30 September 2019.
The Company is, therefore, not prohibited from dealing in its own securities
during the closed period, as defined by the Market Abuse Regulation, which
will end on the date of the publication of its results for the half year ended
30 September 2019, expected to be on or after 12 November 2019.
-ENDS-
For further information please contact:
Mark Pope Frostrow Capital LLP 020 3 008 4913
Copyright (c) 2019 PR Newswire Association,LLC. All Rights Reserved